To assess the potential effect of the AURKB/C inhibitor GSK1070916 on myeloid leukaemia metastases in human ovarian tissue, we first used Western blot analysis to examine AURKB and AURKC expression levels in a panel of six myeloid leukaemia cell lines and in human ovarian cortex. The gene discussed is AURKC; the disease is myeloid leukemia.